Octave

About:

Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.

Website: http://www.octavebio.com

Twitter/X: octavebio

Top Investors: Deerfield, Novartis, Northpond Ventures, Section 32, Michael J. Fox Foundation

Description:

Octave is a clinical platform developer who is working to create a new paradigm of multiple sclerosis care by generating, analyzing, and combining data. The platform of the company provides an integrated and multi-dimensional approach to lowering total cost of care by optimizing healthcare medications and utilization, allowing pharma to optimize the entire lifecycle of drug discovery and development, clinical trials, and post-marketing with real-world evidence.